In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a ...
In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on CVS Health (CVS – Research Report), with a ...
Shares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a move attributed to a potential market launch of a rival kidney disease therapy from Otsuka Holdings ...
9h
Fintel on MSNEvercore ISI Group Upgrades CRISPR Therapeutics (CRSP)Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
UDR (NYSE:UDR – Get Free Report) had its price objective upped by research analysts at Evercore ISI from $43.00 to $45.00 in a research report issued on Monday,Benzinga reports. The firm presently has ...
Evercore ISI’s target price would indicate a potential ... Several institutional investors and hedge funds have recently modified their holdings of the company. ORG Partners LLC bought a new ...
Eric Conley; Senior Vice President and President - Orthodontics; Envista Holdings Corp Elizabeth Anderson; Analyst; Evercore ISI. Jonathan Block; Analyst; Stifel, Nicolaus & Company, Incorporated ...
The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...
HOUSTON, January 17, 2025--(BUSINESS WIRE)--Flowco Holdings Inc. ("Flowco"), a provider ... J.P. Morgan, Jefferies, Piper Sandler and Evercore ISI acted as lead bookrunning managers for the ...
Evercore ISI upgraded Marriott International ( MAR, Financials) to Outperform from In-Line, citing robust travel demand, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results